Top Health Care Reform Stories
Humira beat out Ozempic in 2023 employer plan cost rankings
By Allison BellBut the new GLP-1 agonist obesity and diabetes fighters took up more rungs on Milliman's list of top cash eaters.
The latest news on health care reform and other regulation and compliance issues that are vital to benefits professionals. Insights and commentary about the latest proposals, and innovative strategies and ideas to ensure you stay focused on helping your customers while the debates rage on in Washington.
But the new GLP-1 agonist obesity and diabetes fighters took up more rungs on Milliman's list of top cash eaters.